Literature DB >> 3361305

Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release.

P W Kalivas1, P Duffy.   

Abstract

Daily injections of cocaine or morphine into rodents produces behavioral sensitization such that the last daily injection results in a greater motor stimulant effect than the first injection. To evaluate a role for brain dopamine in behavioral sensitization to cocaine and morphine, tissue slices from the ventromedial mesencephalon (containing dopamine cell bodies), the nucleus accumbens, and striatum (dopamine terminal fields) were obtained from rats pretreated with daily cocaine, morphine, or saline 2-3 weeks earlier. When the tissue slices were depolarized by increasing potassium concentration in the superfusate, the release of endogenous dopamine from the ventromedial mesencephalon of cocaine- and morphine-pretreated rats was significantly decreased. In contrast, the release of dopamine from the nucleus accumbens and striatum was either unaltered or slightly enhanced in rats pretreated with cocaine and morphine. When dopamine was released by amphetamine, a significant decrease in dopamine release from the ventromedial mesencephalon of cocaine-pretreated rats was measured. No other significant changes were measured after amphetamine-induced release. It is postulated that the decrease in dopamine release from the ventromedial mesencephalon of cocaine- and morphine-sensitized rats results in less somatodendritic autoreceptor stimulation, and thereby produces an increase in dopamine neuronal activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3361305     DOI: 10.1111/j.1471-4159.1988.tb03036.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  26 in total

1.  Methamphetamine produces bidirectional, concentration-dependent effects on dopamine neuron excitability and dopamine-mediated synaptic currents.

Authors:  Sarah Y Branch; Michael J Beckstead
Journal:  J Neurophysiol       Date:  2012-05-16       Impact factor: 2.714

2.  Conditioned morphine withdrawal in the hamster.

Authors:  P Schnur
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine.

Authors:  B A Horger; M K Giles; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals.

Authors:  E J Curran; H Akil; S J Watson
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

5.  Dopamine efflux during withdrawal from continuous or intermittent cocaine.

Authors:  G R King; C Kuhn; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration.

Authors:  M Pecins-Thompson; J Peris
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

8.  Effects of dopamine and NMDA receptors on cocaine-induced Fos expression in the striatum of Fischer rats.

Authors:  Wei-Lun Sun; Luyi Zhou; Ruhal Hazim; Vanya Quinones-Jenab; Shirzad Jenab
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

9.  Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats.

Authors:  Wei-Lun Sun; Luyi Zhou; Vanya Quinones-Jenab; Shirzad Jenab
Journal:  Brain Res Bull       Date:  2009-08-28       Impact factor: 4.077

10.  Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.

Authors:  R L Cole; C Konradi; J Douglass; S E Hyman
Journal:  Neuron       Date:  1995-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.